NCT06838169

Brief Summary

Anxiety and sleep disorders are among the most common symptoms in heart failure patients. In addition to pharmacological methods for anxiety and sleep disorders, non-pharmacological methods can also be used. Among these, anxiety and sleep disorders can be prevented with virtual reality glasses aimed at distraction. This study will be conducted to evaluate the effect of breathing exercises performed with virtual reality glasses on anxiety, sleep quality, and respiratory parameters. The study will be conducted with a total of 45 patients, 15 virtual reality glasses + breathing exercises, 15 breathing exercises, and 15 controls. Those in the virtual reality glasses + breathing exercises group will perform breathing exercises with virtual reality glasses once a day for 7 days. Those in the breathing exercises group will perform only breathing exercises once a day for 7 days. Anxiety, sleep disorders, and respiratory parameters of the patients will be examined.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 20, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

July 3, 2025

Status Verified

July 1, 2025

Enrollment Period

Same day

First QC Date

January 16, 2025

Last Update Submit

July 1, 2025

Conditions

Keywords

Heart failureVirtual reality glassesAnxietyRespirationSleep Quality

Outcome Measures

Primary Outcomes (1)

  • Anxiety level

    Turkish adaptation of the state-trait anxiety inventory short version (STAIS-5, STAIT-5). This form is a 4-point Likert type. It is an easy-to-apply inventory consisting of a total of 10 statements. As the score obtained in this form increases, the level of anxiety also increases.

    Apply the morning before application and the morning 7 days after application.

Secondary Outcomes (1)

  • Sleep Quality

    Apply the morning before application and the morning 7 days after application.

Study Arms (3)

Virtual reality glasses + breathing exercise app

EXPERIMENTAL

Virtual reality glasses + breathing exercise app

Behavioral: Virtual reality glassesBehavioral: breathing exercise

Breathing exercise practice

ACTIVE COMPARATOR

Breathing exercise practice

Behavioral: breathing exercise

Kontrol

NO INTERVENTION

No application will be made

Interventions

virtual reality glasses application

Virtual reality glasses + breathing exercise app

breathing exercise app

Breathing exercise practiceVirtual reality glasses + breathing exercise app

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older,
  • Verbal communication,
  • Place and time oriented,
  • Without any psychiatric illness,
  • Patients diagnosed with HF with NYHA class III-IV symptoms,
  • Left ventricular ejection fraction ≥50% (LVEF-CF/HFpEF), between 40-49% (SEF-CF/HFmrEF), HF below 40% (DEF-CF/HFrEF),
  • High levels of natriuretic peptides (BNP\>35 pg/mL and/or NTproBNP\>125 pg/mL),
  • There is no deformity or diagnosis related to the musculoskeletal system that may prevent breathing exercise,
  • Chronic diseases such as hypertension (Stage 1 and 2 HT) and diabetes mellitus are stable and the treatment for these diagnoses has not been changed in the last month,
  • Who have not previously received respiratory exercise training and have not participated in a rehabilitation program,
  • Patients who volunteer to participate in the study will be included in the study

You may not qualify if:

  • Life signs are so abnormal as to preclude intervention,
  • Patients with migraine, vertigo, active nausea-vomiting, headache, dizziness will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

T.C. Erciyes University Faculty of Medicine Hospitals

Kayseri, Talas, 38000, Turkey (Türkiye)

Location

Related Publications (1)

  • Polikandrioti M, Goudevenos J, Michalis LK, Koutelekos J, Kyristi H, Tzialas D, Elisaf M. Factors associated with depression and anxiety of hospitalized patients with heart failure. Hellenic J Cardiol. 2015 Jan-Feb;56(1):26-35.

    PMID: 25701969BACKGROUND

Related Links

MeSH Terms

Conditions

Heart FailureAnxiety DisordersRespiratory AspirationSleep Initiation and Maintenance Disorders

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesMental DisordersRespiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Servet Kalyoncuo

    ERCİYES UNIVERSITY

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Özlem CEYHAN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

January 16, 2025

First Posted

February 20, 2025

Study Start

October 1, 2025

Primary Completion

October 1, 2025

Study Completion

December 30, 2025

Last Updated

July 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations